Re: Acquisition
December 02 2002 - 4:30AM
UK Regulatory
RNS Number:5167E
Goldshield Group PLC
02 December 2002
For Immediate Release: Monday, 2 December 2002
Goldshield Group Plc ("Goldshield")
Decision Not to Pursue Acquisition of Miza Group
As previously announced on 29 October 2002, Goldshield indicated that it was
willing to acquire the Miza Group if acceptable terms and conditions could be
agreed with the examiner.
After careful consideration, Goldshield today announces that it has decided not
to pursue the acquisition of the Miza Group's pharmaceutical manufacturing
business in Ireland.
In the unfortunate event that Miza Pharmaceuticals is unable to continue supply
of products Goldshield is confident of finding alternate suppliers to ensure
minimum impact on sales.
Ajit Patel commented:
"We have thought long and hard about this acquisition and its implications to
our Business going forward - I am confident that we have made the right
decision."
- ENDS -
For Further Information, Please Contact:
Goldshield Group PLC Tel: +44 (0) 20 8649 8500
Ajit Patel, Executive Chairman
Rakesh Patel, Finance Director
Buchanan Communications Tel: +44 (0) 20 7466 5000
Louise Bolton
Notes to editors:
Goldshield Group plc is a growing and profitable, marketing-led, British
pharmaceutical company based in Croydon, Surrey, it was founded in 1990, to sell
healthcare and pharmaceutical products internationally. In June 1998 Group
floated on the London Stock Exchange and currently has a market capitalisation
of around #125 million.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCFSUSUESESEFE
Goldshield (LSE:GSD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Goldshield (LSE:GSD)
Historical Stock Chart
From Jul 2023 to Jul 2024